SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rubius Therapeutics, Inc.

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Rubius Therapeutics, Inc. ("Rubius" or the "Company") (NASDAQ: RUBY). Such...

Related Keywords

New York ,United States ,Paris ,France General ,France ,Chicago ,Illinois ,Tel Aviv ,Israel ,Los Angeles ,Abrahaml Pomerantz ,Roberts Willoughby ,Prnewswire Pomerantz ,Rubius Therapeutics Inc ,Nasdaq ,Rubius Therapeutics ,Updated Clinical Data ,Advanced Solid Tumors ,Although Rubius ,Pomerantz Llp ,